American International Group, Inc. Logic Bio Therapeutics, Inc. Transaction History

American International Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.03 - $7.57 $38,522 - $72,361	-9,559 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$6.8 - $9.16 $176 - $238	26 Added 0.27%	9,559 $70,000
Q4 2020 Feb 12, 2021	BUY	$5.29 - $9.1 $11,844 - $20,374	2,239 Added 30.7%	9,533 $73,000
Q3 2020 Nov 04, 2020	SELL	$5.41 - $9.45 $346 - $604	-64 Reduced 0.87%	7,294 $66,000
Q2 2020 Aug 12, 2020	BUY	$4.25 - $8.46 $10,378 - $20,659	2,442 Added 49.67%	7,358 $62,000
Q1 2020 May 04, 2020	SELL	$4.06 - $11.0 $1,157 - $3,135	-285 Reduced 5.48%	4,916 $24,000
Q4 2019 Feb 05, 2020	BUY	$7.01 - $11.01 $112 - $176	16 Added 0.31%	5,201 $37,000
Q3 2019 Nov 08, 2019	SELL	$6.97 - $13.46 $913 - $1,763	-131 Reduced 2.46%	5,185 $56,000
Q2 2019 Aug 13, 2019	BUY	$9.77 - $17.08 $3,116 - $5,448	319 Added 6.38%	5,316 $69,000
Q1 2019 May 06, 2019	SELL	$7.93 - $10.41 $2,799 - $3,674	-353 Reduced 6.6%	4,997 $49,000
Q4 2018 Feb 13, 2019	BUY	$7.88 - $17.98 $42,158 - $96,193	5,350 New	5,350 $56,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.